The Glaucoma and Retinopathy Screening Study
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of
| Condition(s) | Glaucoma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma. Participants will: Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset |
| Who can participate | * Individuals with diabetes undergoing AI-based screening for diabetic retinopathy using the LumineticsCore (Digital Diagnostics) system for clinical care at primary care centers. * Individuals who are able and willing to provide informed consent for participation in the study. |
| Ages | 40 Years |
| Sex | All |
| Lead sponsor | Massachusetts Eye and Ear Infirmary |
| Locations | Boston, Massachusetts, United States; Chelsea, Massachusetts, United States; Lynn, Massachusetts, United States; Salem, Massachusetts, United States; Saugus, Massachusetts, United States |
| Start date | 2025-07-16 |
| NCT ID | NCT06882356 |
| Official listing | https://clinicaltrials.gov/study/NCT06882356 |